BMS, Ono, and Bayer partner to trial combination therapy for mCRC

BMS’ clinical collaboration with Ono and Bayer will see investigation of combination therapy for metastatic colorectal cancer. Credit: A 4/Flickr.



  • BMS, Ono and Bayer to trial Opdivo plus Stivarga